Why Is The FDA Concerned About Secondary Cancers After CAR T Cells?

Back in November, the FDA announced that it was looking into reports of secondary cancers potentially caused by the use of CAR T cells in a small number of patients.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news